L-Thyroxin Serb (Levothyroxine Sodium)

Levothyroxine sodium is a synthetic form of thyroxine (T4). After injection, it enters the bloodstream and binds to nuclear thyroid hormone receptors, influencing gene expression that controls metabolic rate, protein synthesis, and growth. By supplementing deficient hormone, it normalizes metabolic processes throughout the body.

The appropriate dose of L‑Thyroxin Serb is individualized. A qualified prescriber determines the exact amount based on the patient’s thyroid function tests, clinical condition, age, weight, and other factors. Dosage adjustments are made to achieve optimal hormone levels.

Levothyroxine is generally considered safe in pregnancy and lactation when clinically indicated, as untreated hypothyroidism can harm both mother and fetus. However, dosing may need adjustment, and the prescriber should evaluate the risk‑benefit ratio for each patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

L‑Thyroxin Serb delivers levothyroxine via intramuscular or intravenous injection, which can be useful when oral administration is not feasible. Oral levothyroxine tablets are more common for routine therapy, while injectable forms provide rapid and controlled delivery in hospital settings or for patients with absorption issues.

L‑Thyroxin Serb should be stored at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze or shake the product. Follow any additional handling instructions provided by the supplier to maintain stability and potency.

The product is administered by a healthcare professional via intramuscular or intravenous injection. The injection site and rate are determined by the prescriber based on the patient’s clinical needs and the intended therapeutic effect.

Serious risks include cardiac arrhythmias, symptoms of overt hyperthyroidism such as rapid heart rate, tremor, and weight loss, as well as rare allergic reactions that may cause rash, swelling, or breathing difficulties. Patients should be monitored regularly for these adverse events.

Individuals with known hypersensitivity to levothyroxine or any excipients in the formulation should avoid use. Caution is also advised for patients with untreated adrenal insufficiency, recent myocardial infarction, or uncontrolled cardiovascular disease, where levothyroxine may exacerbate symptoms.